The Associated Press @AP
Who should pay for patients with a deadly diagnosis to receive experimental drug treatments? For decades, the cost was borne by drugmakers. But ALS patients-- backed by Congress-- have found a new solution: the federal government. https://t.co/qw7ZethyMO — PolitiTweet.org
